The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Trials 9708 and 9905

• Larissa J. Lee ,

  Contributed equally to this work with: Larissa J. Lee, Elena Ratner

  Affiliation Department of Radiation Oncology, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Elena Ratner ,

  Contributed equally to this work with: Larissa J. Lee, Elena Ratner

  Affiliation Department of Gynecologic Oncology, Yale University, New Haven, Connecticut, United States of America

  ⨯
• Mohamed Uduman,

  Affiliation Interdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, United States of America

  ⨯
• Kathryn Winter,

  Affiliation Statistical Center, Radiation Therapy Oncology Group (RTOG), Philadelphia, Pennsylvania, United States of America

  ⨯
• Marta Boeke,

  Affiliation Department of Gynecologic Oncology, Yale University, New Haven, Connecticut, United States of America

  ⨯
• Kathryn M. Greven,

  Affiliation Department of Radiation Oncology, Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States of America

  ⨯
• Stephanie King,

  Affiliation Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Thomas W. Burke,

  Affiliation Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Kelly Underhill,

  Affiliation Department of Radiation Oncology, Benefis Sletten Cancer Institute, Great Falls, Montana, United States of America

  ⨯
• Harold Kim,

  Affiliation Department of Radiation Oncology, Wayne State University Karamanos Cancer Center, Detroit, Michigan, United States of America

  ⨯
• Raleigh J. Boulware,

  Affiliation Radiation Oncology, South Carolina Oncology Associates, Columbia, South Carolina, United States of America

  ⨯
• Herbert Yu,

  Affiliations Department of Chronic Disease and Epidemiology, Yale University, New Haven, Connecticut, United States of America, Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America

  ⨯
• Vinita Parkash,

  Affiliation Department of Pathology, Yale University, New Haven, Connecticut, United States of America

  ⨯
• Lingeng Lu,

  Affiliation Department of Chronic Disease and Epidemiology, Yale University, New Haven, Connecticut, United States of America

  ⨯
• David Gaffney,

  Affiliation Department of Radiation Oncology, University of Utah Huntsman Cancer Hospital, Salt Lake City, Utah, United States of America

  ⨯
• Adam P. Dicker,

  Affiliation Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States of America

  ⨯
•  [ ... ],
• Joanne Weidhaas

  * E-mail: joanne.weidhaas@yale.edu

  Affiliation Department of Therapeutic Radiology, Yale University, New Haven, Connecticut, United States of America

  ⨯
• [ view all ]
• [ view less ]